This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Indian government directed to invoke compulsory licensing for drugs to treat Covid-19 patients

By Freny Patel ( April 27, 2021, 09:26 GMT | Insight) -- An Indian court has directed the government to invoke compulsory licensing if it is unable to "encourage" pharmaceutical companies to ramp up the production of drugs to treat Covid-19 patients, because thousands of lives are at stake.As India battles a second wave of the Covid-19 pandemic and faces a shortage of life-saving drugs, the Delhi High Court has directed the government to invoke its powers of compulsory licensing under the Patent Act if all else fails....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections